China didn't "drew the line". China the buyer wants to buy gold as cheap as possible. US also wants gold cheap so US$ look good. Our Keynesian economists at the Treasuries and Federal Reserve have dumped gold (somebody else's gold , OURs) to prove their theory.
I think t0 can actually do it. Its only a clinical trial ,years before Geron make real dough if it wins approval. Current valuation $800 million is fairly high for a clinical stage company thus the sell off from November high. Inability to rally is the tell.
I'm hoping for gradual climb to ASH, then pop 35% on ASH. I will sell into the POP.
This was $1.20 early in the year. so sell of the news is pretty heavy. We now have two very good studies from University of Bern and Mayo Clinic. Definitely worth holding for a few years.
Essential Thrombocythemia treatment, patients average time 14 month achieved 89% Complete Remission. Its in their June 16 update. Combine those two study results we can conclude CR rate gets better with time. This study is no fluke.
And University of Bern ,Hospitla is also frauster ? That study on ET has patients enrolled longer than a year. Complete Remission all around.
I was in that one. Bailed out too early also missed the big slump. They touted 200k per treatment for a potential 50000 patients only. The treatment extends terminaly ill by only a few days. Total waste of money..